Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 49-60 of 1667 results.
"A 24-week TIVAP maintenance interval after completion of intravenous therapy appeared feasible and safe in this real-world cohort, with no infections and excellent port survival" Pina-Cabral et al (2026).
"Clinical pharmacist intervention via implementing infection control within the context of a pharmaceutical-care process can improve infection rates among hemodialysis patients" Obeid et al (2026).
"Reduction of CLABSI rates is a top priority for Level IV NICUs due to the significant short- and long-term impacts for patients. Benchmarking with other NICUs is a valuable practice when neonatal-specific research is unavailable" Velasco et al (2026).
"The rates of tunnelled haemodialysis catheter failure have fallen significantly over the past 25 years. Improvements in catheter outcomes underscore the contemporary importance of an individualised approach to dialysis access" Yaxley et al (2026).
"This study evaluates the efficacy of low-concentration TSC versus low-concentration UFH as CLAs in hemodialysis CVCs" Pattharanitima et al (2026).
"This systematic review advances current knowledge by synthesising available evidence on paediatric OPAT program organisation, clinical outcomes, and safety, and by identifying key gaps to inform future program development and standardisation" Ciudad-Gutiérrez et al (2026).
"This study aimed to quantify the differential risks of UPR triggered by distinct complication types, including infection, thrombosis, mechanical complications, and catheter-associated skin injury" Zhou et al (2026).
"While IO access enables rapid vascular access for resuscitation and reduces critical intervention time, despite its procedural efficiency in rapid vascular access for resuscitation, IO may inadvertently aggravate systemic inflammatory dysregulation, impair hematopoietic function, and worsen coagulation-metabolic disturbances through mechanisms such as mechanical stimulation, hypothermic fluid infusion, and oxidative stress" Deng et al (2026).
"In catheter-dependent HD patients, Staphylococcus aureus is the predominant organism associated with both CRBSI and IE. With an observed IE occurring in 9.4% hospitalized catheter-dependent HD patients with CRBSI, consistent compliance with prevention bundles must be prioritized as a standard of care for catheter management" Bora et al (2026).
"In-line filters were associated with reduced CRBSI, indicating potential benefit in preventing infusion-related contamination" Kato et al (2026).
"This study aimed to examine the prevalence and associated risk factors of TIVAD-related venous thrombosis in breast cancer patients undergoing chemotherapy" Li et al (2026).
"This meta-analysis aimed to compare the incidence of CRBSI between PICCs and tunneled CVCs in patients receiving home parenteral nutrition" Zheng et al (2026).
